Ray Therapeutics has filed a notice of an exempt offering of securities to raise $99,999,956.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Ray Therapeutics is raising $99,999,956.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Paul Bresge played a key role…
